FDA needs to improve its access to data if it is to manage drug shortages more effectively, the Government Accountability Office concluded.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
